Aslak Aslaksen • 1959 • Oslo • 21 roles • 13 shareholdings

Roles

Name	Role	Total operating income	Total equity	Shares
A A A HOLDING AS	Chairman	-	6,059,476	100 % directly
N NORDBOTN KRAFTVERK AS	Board Member	-	-	20 % indirectly
S SANDHAUGEN VINDKRAFTVERK AS	Board Member	-	-9,394,805	13.51 % indirectly
N NORSK MILJØKRAFT CONSULT AS	Board Member	-	-374,853	13.5 % indirectly
V VIKING ARM AS	Board Member	64,005,703	8,072,982	12.37 % indirectly
N NORSK MILJØKRAFT AS	Board Member	-	-	10.71 % indirectly
V VIKING ARM MEDICAL AS	Board Member	-	-3,232,402	5.56 % indirectly
S SAGA RARE EARTHS HOLDING AS	Board Member	2,338,669	11,554,648	4.98 % indirectly
S SAGA RARE EARTHS AS	Board Member	-	681,758	4.98 % indirectly
I IMMUNOR AS Under liquidation	Board Member	-	-105,943	2.97 % indirectly
R RÅDGIVER ASLAKSEN	Holder	168,753	428,057	-
B BOLIGSAMEIET DAMMANNS VEI 9	Business Manager	-	-	-
N NORSK FOLKEMUSEUMS VENNER Closed	Board Member	-	-	-
F FORTIDSMINNEFORENINGEN I OSLO OG AKERSHUS	Board Member	-	-	-
P PERIOVACX AS Under liquidation	Board Member	-	-219,944	-
S SAMEIET MELTZERSGATE 16	Board Member	908,135	733,010	-
P PHOTOSYNTHETIC AS	Board Member	-	-	-
N NSN HOLDING AS	Board Member	-	28,325	-
A ADVENTURE GROUP AS	Board Member	14,206,425	63,765	-
H HYDMAGS AS	Board Member	-	11,493	-

Last update: Apr 30, 2026

Name	Share class	Total operating income	Total equity	Share
A A A HOLDING AS	B-aksjer A-aksjer	0 0	6,059,476 6,059,476	90 % directly 100 % 10 % directly 100 %
N NORDBOTN KRAFTVERK AS		0	0	20 % indirectly
S SANDHAUGEN VINDKRAFTVERK AS		0	-9,394,805	13.51 % indirectly
N NORSK MILJØKRAFT CONSULT AS		0	-374,853	13.5 % indirectly
V VIKING ARM AS		64,005,703	8,072,982	12.37 % indirectly
B BIONOR IMMUNO AS Under liquidation		0	-17,118,793	11.09 % indirectly
B BIONOR HOLDING AS Under liquidation		0	-819,407	11.09 % indirectly
N NORSK MILJØKRAFT AS		0	0	10.71 % indirectly
V VIKING ARM MEDICAL AS		0	-3,232,402	5.56 % indirectly
S SAGA RARE EARTHS HOLDING AS		2,338,669	11,554,648	4.98 % indirectly
S SAGA RARE EARTHS AS		0	681,758	4.98 % indirectly
I IMMUNOR AS Under liquidation		0	-105,943	2.97 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025